| Baseline | 1-week follow-up | 3-month follow-up |
---|---|---|---|
Demographic (collected via EHR and patient survey) | X | Â | Â |
Medications and comorbidities (collected via EHR and patient survey) | X | Â | Â |
Primary outcomes—patient-reported and/or electronic health record | |||
 CVD risk assessment (discuss with doctor the results of cholesterol test or having a cholesterol test, if not done at enrollment) | - | X | X |
 Initiating lipid-lowering therapy, if indicated | - | X | X |
Secondary outcomes—patient-reported | |||
 RAPID-3 | X | X | X |
 Social Support Survey (SSS) | X | X | X |
 General Self-Efficacy Scale (GSE) | X | X | X |
 Patient Activation Measure (PAM) | X | X | X |
 Patient Health Questionnaire-8 (PHQ-8) | X | X | X |
 Medication Understanding and Use Self-Efficacy Scale (MUSE) | X | X | X |